Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis

X Zhou, Z Yao, H Bai, J Duan, Z Wang, X Wang… - The Lancet …, 2021 - thelancet.com
Background Numerous ongoing trials are testing anti-PD-1-based or anti-PD-L1-based
cancer treatment combinations. Understanding the toxicity profiles of treatment-related …

Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis

X Zhou, Z Yao, H Bai, J Duan, Z Wang, X Wang… - The Lancet …, 2021 - Elsevier
Background Numerous ongoing trials are testing anti-PD-1-based or anti-PD-L1-based
cancer treatment combinations. Understanding the toxicity profiles of treatment-related …

Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis

X Zhou, Z Yao, H Bai, J Duan, Z Wang… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Numerous ongoing trials are testing anti-PD-1-based or anti-PD-L1-based
cancer treatment combinations. Understanding the toxicity profiles of treatment-related …

Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis.

X Zhou, Z Yao, H Bai, J Duan, Z Wang, X Wang… - The Lancet …, 2021 - europepmc.org
Background Numerous ongoing trials are testing anti-PD-1-based or anti-PD-L1-based
cancer treatment combinations. Understanding the toxicity profiles of treatment-related …

[PDF][PDF] Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis

X Zhou, Z Yao, H Bai, J Duan, Z Wang… - The Lancet …, 2021 - drive.google.com
Background Numerous ongoing trials are testing anti-PD-1-based or anti-PD-L1-based
cancer treatment combinations. Understanding the toxicity profiles of treatment-related …

[引用][C] Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis

X Zhou, Z Yao, H Bai, J Duan, Z Wang, X Wang… - The Lancet …, 2021 - cir.nii.ac.jp
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in
clinical trials: a systematic review and meta-analysis | CiNii Research CiNii 国立情報学研究所 …